Does Dr. YAMAN ALALI have financial conflicts of interest?

Dr. YAMAN ALALI (MD) has received a total of $1,247 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $1,247 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. YAMAN ALALI?

According to CMS Open Payments data, Dr. YAMAN ALALI received funding from ASTRAZENECA PHARMACEUTICALS ($186), SEAGEN ($184), and ASTELLAS PHARMA US ($176).

Does Dr. YAMAN ALALI receive research grants or speaking fees?

Dr. YAMAN ALALI has received $1,247 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. YAMAN ALALI

MDReal-Time Hydrated

Specialty: Internal Medicine, Hematology & Oncology

Practice Location: TOPEKA, KS 66606

NPI Number: 1134781941

LIFETIME INDUSTRY VALUE

$1,247

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ALALI is a verified Internal Medicine, Hematology & Oncology practitioner based in TOPEKA, KS.

Between 2021 and 2024, Dr. ALALI had an overall industry promotional and research financial footprint of $1,247 as recorded in the federal CMS Open Payments database.

$1,247 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALALI's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $186 (representing 15% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS

Rank 1

$186

15%

SEAGEN

Rank 2

$184

14.8%

ASTELLAS PHARMA US

Rank 3

$176

14.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.